Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an Adjuvant to Bupivacaine for Post-Mastectomy Pain
NCT07683416Active, not recruiting
- Sponsor
- Zagazig University
- Start
- Jun 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Zagazig University. Primary endpoint: Total opioid consumption at 24 hours. Started Jun 2026; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07683416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07683416.